PROVIDER PROFILE · NPI 1003084120
Arash Nowain
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
100
Beneficiaries
—
Total drug cost
$23K
Distinct drugs
4
Brand share
27.0%
Top prescribed drugs
QUALITY · MIPS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK
Where Arash Nowain's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Path Md, Inc. Clinical Laboratory · Los Angeles, CA | 16 | 19 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 15 | 50 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| La Peer Surgery Center, Llc Ambulatory Surgical Center · Beverly Hills, CA | 34 | 74 |
| Path Md, Inc. Clinical Laboratory · Los Angeles, CA | 32 | 70 |
| CEDARS-SINAI MEDICAL CENTER | 30 | 90 |
| Laboratory Corporation Of America Clinical Laboratory · San Diego, CA | 24 | 67 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE